Northcape Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Northcape Wealth Management's PFE Position: Q2 2026 in Review
Northcape Wealth Management reduced its Pfizer (PFE) stake by 0.85% in Q2 2026, selling an estimated $6.12K and leaving 27,196 shares worth $655K. The position accounts for 0.17% of the portfolio, ranked #93.
Northcape Wealth Management first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.15M in Q1 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Northcape Wealth Management held 27,196 shares of Pfizer worth $655K as of Q2 2026.
- Northcape Wealth Management sold 234 Pfizer shares in Q2 2026, an estimated $6.12K.
- Pfizer made up 0.17% of Northcape Wealth Management's portfolio in Q2 2026, its #93 holding.
- Northcape Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Northcape Wealth Management's Pfizer position peaked at $2.15M in Q1 2022.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Northcape Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.